G lucose in very high concentrations (75 -215 mmol/L) is used as an osmotic agent in conventional glucose-based peritoneal dialysis (PD) fluids. Cytotoxic effects of these PD fluids are known (1, 2) . Low pH and high osmolality have been determined to be factors affecting the biocompatibility of these PD fluids, with the toxicity most related to the initial low pH of 5.4 (3) . However, there is considerable evidence that the bioincompatibility of conventional glucose-based PD fluids is not caused by low pH alone, since several negative side effects persisted in neutralized PD fluids (3) . Conventional heat-sterilized PD fluids are cytotoxic in contrast to PD fluids sterilized by filtration (1, 4, 5) . The process of heat sterilization of glucose-based PD fluids leads to the formation of glucose degradation products (3, (6) (7) (8) (9) and there is considerable evidence that the cytotoxicity of PD fluids may partly originate from these glucose degradation products (3, (10) (11) (12) (13) . The presence of several aldehydes and 1,2-dicarbonyl compounds has been demonstrated in PD fluids (3, 7, 14) . The occurrence of these compounds caused cytotoxicity in vitro (3, 12) , although the magnitude of the toxicity found in PD fluids suggested the presence of additional unidentified glucose degradation products (12) . In addition, the induced formation of advanced glycation end-products (AGEs) (15) may contribute to the in vivo toxicity of PD fluids.
Initially, glucose reacts nonenzymatically and reversibly with free amino groups of proteins to form a Schiff 's base, which undergoes an Amadori rearrange-ment to form early glycated products that subsequently undergo irreversible complex molecular fragmentation and rearrangements to form AGEsheterogeneous structures with characteristic fluorescence. The formation of AGEs is very complex and the mechanism is not completely understood, but 1,2-dicarbonyl compounds, particularly 3-deoxyglucosone (3-DG) (16) and methylglyoxal (MGO) (17) , have been identified as intermediates in nonenzymatic glycation.
Heat-sterilized PD fluids were recently reported to promote the formation of early and late glycation end-products (18) (19) (20) . During PD treatment the peritoneal membrane is continuously exposed to extremely high glucose concentrations, and glycated albumin has been detected in dialysates (21) . In addition, AGEs have been demonstrated to accumulate in the peritoneal membrane and the omentum after chronic continuous ambulatory peritoneal dialysis (CAPD) treatment (22, 23) . Similarly to pathological changes seen in diabetes (15) , glycation of the peritoneal membrane may lead to peritoneal membrane thickening and may be responsible for the pathogenesis of complications such as ultrafiltration failure.
One aim of the present study was to quantify 1,2-dicarbonyl compounds in different brands of commercial glucose-based PD fluids and to determine the effect of heat sterilization on the formation of these compounds. Another aim was to determine the in vitro formation of AGEs in different heat-and filter-sterilized glucose-containing PD fluids in the presence of albumin and to elucidate the role of 1,2-dicarbonyl compounds in this process. Finally, the concentrations of dicarbonyl compounds and the appearance of AGEs were measured in PD patients' effluents collected at specific time intervals from a standardized 4-hour dwell.
METHODS

REAGENTS
Human serum albumin (HSA) was obtained from the Central Laboratory of Blood Transfusion (Amsterdam, the Netherlands). Methylglyoxal was prepared fresh by the acid hydrolysis of 1,1-dimethoxyacetone (Sigma Chemical Co., St. Louis, MO, U.S.A.) and purified by distillation as described (24) . The concentration of MGO was determined as described (25). 3-Deoxyglucosone was prepared as described (26) and purified with a Kieselgel 60 column (Merck, Darmstadt, Germany) with pentane/ethylacetate/methanol (2:1:1) as the solvent system. Decolorization was carried out with activated carbon. The preparation was dried over P 2 O 5 . Thin layer chromatography (silica gel 60) and 1 H-NMR (nuclear magnetic resonance) analysis indicated a pure substance. Glyoxal (GO) and aminoguanidine were obtained from Sigma Chemical Co. Gradient grade ethanol (LiChrosolv) was purchased from Merck and high performance liquid chromatography (HPLC) grade acetonitrile (Hipersolv) from BDH (Poole, U.K.). 1,2-Diamino-4,5-dimethoxybenzene (DDB) was obtained from Molecular Probes (Eugene, OR, U.S.A.).
Three different conventional brands of PD fluids were analyzed: Dianeal (1.36%, 2.27%, and 3.86% glucose; Baxter BV, Utrecht, The Netherlands), Gambrosol (1.5%, 2.5%, and 4.0% glucose; Gambro BV, Breda, The Netherlands), and Lockolys (1.5%, 2.3%, and 4.25% glucose; Fresenius AG, Bad Homburg, Germany). To determine the effect of heat sterilization, PD fluids with the same composition as the conventional heat-sterilized PD fluids from Baxter were made (Baxter RND, Nivelles, Belgium). These laboratory-made fluids were sterilized by filter-sterilization through a 0.22 µ filter. The analysis of the dicarbonyl compounds in the conventional and laboratory-made fluids was done on three different batches.
PATIENTS
Eight, stable, adult nondiabetic patients on continuous cycling peritoneal dialysis (CCPD) were included in the effluent study (duration on PD 37.4 ± 9.5 months). None of the patients had experienced signs or symptoms of peritonitis 4 weeks prior to participation in the study. During a standardized 4-hour dwell with Dianeal 1.36%, effluents were collected at 10, 60, 120, and 240 minutes. The cells were separated by centrifugation at 1.000g for 10 minutes at 4°C and the cell-free supernatants were stored at -70°C until analysis.
ANALYSIS OF 1,2-DICARBONYL COMPOUNDS
Glyoxal, MGO, and 3-DG were determined by reverse-phase HPLC with gradient elution after derivatization to their respective dimethoxyquinoxaline derivatives according to a modification of a previously reported method for the detection of MGO (25) . Briefly, a 50 µL aliquot of sample was mixed with 0.20 mL 0.1 mol/L potassium phosphate buffer (pH 7.0), 0.20 mL ethanol, and 50 µL of freshly prepared derivatization reagent (20 mmol/L DDB dissolved in 10 mmol/L HCl). The mixture was incubated at ambient temperature for at least Samples (5 µL) were injected and separation was performed with a linear gradient from 0% -35% mobile phase B over 12 minutes. At 13 min the gradient was returned to initial conditions and the column was equilibrated for 5 min before injection of the next sample. The flow rate was set at 1.0 mL/min and fluorescence detection was performed with excitation and emission wavelengths of 352 nm and 385 nm, respectively. Quantitation was based on peak area measurement using external standardization. Calibration curves of peak area versus concentration were linear up to 1000 µmol/L (correlation coefficients > 0.9999) for all components. The lower limit of determination at a signal/noise ratio of 10 was approximately 0.1 µmol/L. Recoveries determined by spiking dialysis fluid samples with exogenous oxoaldehydes were between 94% and 103%. Within-day precision expressed as coefficient of variation was better than 1.5% for all components.
INCUBATION PROCEDURES
Human serum albumin (50 mg/mL) was incubated with solutions of glucose (0.5 mol/L) or 1,2-dicarbonyl compounds (GO, MGO, or 3-DG; 5 mmol/L each) in 0.1 mol/L phosphate buffer (pH 7.4) at 37°C in the dark. Aliquots were removed after the indicated incubation times, dialyzed against phosphate-buffered saline (PBS), and stored frozen at -20°C until analyzed. To study AGE formation in different PD fluids, HSA (10 mg/mL) was incubated in 90% (v/v) PD fluids, buffered with 0.05 mol/L phosphate buffer (pH 7.4) without or with aminoguanidine (200 mmol/L) at 37°C in the dark. Aliquots were sampled, dialyzed against PBS, and frozen at -20°C.
ANALYSIS OF AGE FLUORESCENCE
The formation of AGEs upon the incubation of albumin with PD fluids or 1,2-dicarbonyl compounds was measured by AGE-specific fluorescence at 430 nm upon excitation at 350 nm with a fluorescence spectrophotometer (Perkin-Elmer, Nieuwerkerk aan den Yssel, The Netherlands) as previously described (18) .
STATISTICS
Differences in time in the effluent study were assessed by analysis of variance (ANOVA). Log transformation was necessary for statistical analysis. The ANOVA was followed by multiple comparison, using the paired t-test, applying the Bonferroni correction.
RESULTS
To determine the presence of reactive 1,2-dicarbonyl compounds in PD fluids, we first developed a novel HPLC assay for the measurement of these compounds. The chromatogram of the reference compounds GO, MGO, and 3-DG and a characteristic chromatogram of a commercial heat-sterilized PD fluid are shown in Figure 1 . The concentrations of 3-DG, MGO, and GO in different brands of commercial PD fluids are summarized in Table 1 . The heatsterilized fluids contained significant amounts of MGO (range 3.7 -14.5 µmol/L) and GO (range 2.7 -29.8 µmol/L), and much higher concentrations of 3-DG (range 168 -582 µmol/L). Minor differences were observed in the concentrations of these 1,2-dicarbonyl compounds between different brands of PD fluids (Table 1) .
We compared heat-sterilized PD fluids (Dianeal 1.36% -3.86% glucose) with filter-sterilized PD fluids with the same composition in order to study whether the presence of these 1,2-dicarbonyl compounds is related to the process of heat sterilization. Levels of 3-DG, MGO, and GO in filter-sterilized glucose-containing fluids were significantly lower compared with heat-sterilized PD fluids (p < 0.005) (Figure 2 ).
When incubated with albumin, the 1,2-dicarbonyl compounds 3-DG, MGO, or GO yielded, in all cases, a time-dependent increase of AGE fluorescence (Figure 3) . Compared with glucose, the 1,2-dicarbonyls were much more potent and rapid in the formation of AGE fluorescence. The inhibitor aminoguanidine completely suppressed glucose-and 1,2-dicarbonylinduced AGE formation (data not shown).
In addition, we compared the formation of AGEs in heat-sterilized PD fluids with laboratory-made filtersterilized PD fluids (Figure 4 ). The formation of AGEs increased significantly during the incubation of HSA in conventional heat-sterilized glucose-based PD fluids. The development of AGE fluorescence was completely inhibited by aminoguanidine (data not shown). The formation of AGEs was time-and glucose concentration-dependent (ANOVA, p < 0.0005), with the rate of AGE formation being highest within the first day. The formation of AGEs was significantly lower in filter-sterilized PD fluids compared with heat-sterilized PD fluids (p < 0.005); although, in filter-sterilized PD fluids, a time-and glucose concentration-dependent formation of AGEs was observed as well (ANOVA, p < 0.0005).
In effluents collected at timed intervals from 4-hr dwells of 8 PD patients, the concentration of MGO, GO, and 3-DG decreased with increasing dwell time (ANOVA, p < 0.005) ( Figure 5) . Remarkably, the concentration of MGO, but not GO or 3-DG, increased significantly from 120 to 240 minutes (from 0.27 ± 0.06 to 0.39 ± 0.09 µmol/L; paired t-test, p < 0.005). The decrease in the concentrations of the 1,2-dicarbonyl compounds was accompanied by an increase in AGE fluorescence in the effluents (ANOVA, p < 0.005) (Figure 6 ).
DISCUSSION
Factors in PD fluids that have been reported to have detrimental side effects in patients on PD include glucose-degradation products and AGEs. The formation of AGEs is very complex due to several possible metabolic pathways, but glucose-degradation products such as 1,2 dicarbonyl compounds have recently received considerable attention as mediators in the formation of a variety of AGEs (15, 27, 28) . We confirmed the presence of 3-DG, GO, and MGO (7, 14) in PD fluids and demonstrated that the high concentrations of 3-DG, MGO, and GO in conventional heat-sterilized PD fluids are a consequence of the process of heat sterilization. 3-Deoxyglucosone was identified as the major 1,2-dicarbonyl compound formed during heat sterilization of glucose-based PD fluids (Figures 1 and 2 and Table 1 ). The amount of 3-DG was approximately 25 -60 times higher than GO and MGO in PD fluids.
Only minor differences were observed in the concentrations of these 1,2-dicarbonyl compounds between different brands of PD fluids. We demonstrated that glucose and the 1,2-dicarbonyl compounds 3-DG, MGO, and GO, when incubated in vitro with HSA, induced a rapid formation of AGEs. Our observations confirm a strong accelerated formation of AGE products by conventional heatsterilized PD fluids compared with filter-sterilized PD fluids (18, 19) , indicating that conventional heat-sterilized PD fluids contain factors, which are induced by the process of heat sterilization, that promote the formation of AGEs. The presence of high concentrations of dicarbonyl compounds and the speed of AGE formation by heat-sterilized PD fluids compared with filter-sterilized PD fluids, and the observation that AGE formation was completely suppressed by aminoguanidine, a trapping reagent specific for dicarbonyl compounds (29, 30) , strongly suggest that dicarbonyl compounds, rather than glucose itself, are the main direct precursors of AGEs in heat-sterilized PD fluids.
In spite of the high concentrations of 3-DG in conventional heat-sterilized PD fluids, the serum concentration of 3-DG was not significantly higher in CAPD patients compared with hemodialysis patients (29) , indicating no preferential peritoneal transport of 3-DG across the peritoneum. The increase in AGE fluorescence in the effluents, accompanied by a decrease in the dicarbonyl compounds ( Figures 5 and  6) , suggested, however, a direct interaction of these dicarbonyl compounds with proteins in PD fluids. In addition to the direct interaction of dicarbonyl compounds with proteins in the PD fluid, AGE fluorescence as measured in the effluents may also be due to a "wash out" of local AGE from the peritoneum, formed by long-term intraperitoneal exposure to glu- cose and dicarbonyl compounds. Furthermore, transperitoneal diffusion of AGEs may contribute to AGE accumulation in the dialysates. Alternatively to a direct interaction of 3-DG with proteins in PD fluids, 3-DG might also be transported across the peritoneal membrane but metabolized. It has been demonstrated in rats that intravenously injected 3-DG was rapidly metabolized by 2-oxoaldehyde reductase to 3-deoxyfructose and excreted in urine, with the excreted quantity highest at 1 hour after administration (30) . In this respect, the high level of 3-DG reductase in the liver is thought to be important (31) . Another possibility may be that 3-DG, upon transport across the peritoneal membrane and by interaction with plasma proteins, is involved in the formation of AGEs in the circulation. Both 1,2-dicarbonyl compounds and AGEs may be linked to complications in the peritoneum. Recently, the cytotoxic effect of MGO and 3-DG was studied. These dicarbonyl compounds induced apoptotic cell death in macrophage-derived cell lines (32) and growth arrest of the cell cycle, toxicity, and apoptosis in human leukemia 60 cells (33) . Furthermore, MGO and 3-DG selectively increased intracellular peroxide levels (34) , and an increased oxidative stress is a strong inducer of cell activation. Recently, it has been shown that MGO-modified proteins stimulate the synthesis of interleukin-1β, tumor necrosis factor-α, and macrophage-colony stimulating factor in monocytes and macrophages (35) (36) (37) . In addition to the effects of 1,2-dicarbonyl compounds, AGEs have been implicated in many of the complications of diabetes. They can alter the structural properties of the extracellular matrix by inducing collagen cross-linking and basement membrane thickening (15) , resulting in an increase in permeability (38, 39) and affecting attached cell behavior (15) . Therefore, we consider that the presence of 1,2-dicarbonyl compounds and AGEs in PD fluids, and the accumulation of AGEs in the peritoneal membrane and the omentum after chronic PD treatment, are involved in the pathogenesis of complications during PD, although other glucose-degradation products and pH may be involved as well.
When 1,2-dicarbonyl compounds and AGEs are proved to be relevant to the pathogenesis of these complications, changes in the process of heat sterilization to reduce the formation of 1,2-dicarbonyl compounds to improve the quality of PD fluids is recommended. Recently, Wieslander and co-workers demonstrated significantly lower levels of 3-DG and MGO in a multicompartment bag with a small compartment containing highly concentrated glucose at a low pH (14, 40) . Dawnay and Millar (19) have recently demonstrated that the in vitro formation of glycated albumin and AGEs is significantly lower with the glucose polymer icodextrin than with glucose. Alternatively, addition of aminoguanidine to PD fluids in order to trap reactive 1,2-dicarbonyl compounds and prevent AGE formation might be considered.
